Biotech innovation stuck at the start
The Russian biotechnological innovation company "Eurogen" sells its technologies and products all over the world. Lukyanov is convinced that his company, armed with modern devices, would have a real chance to make a revolution in biomedicine and take a leading position in the development of new approaches to the treatment of oncological and autoimmune diseases. He knows other companies that could "jerk" if not for financial constraints.
13.04.2009